SCHEMBL6646237

SCHEMBL6646237

O=C(O)N1CC=CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6647135 0.74 CHRNB2 (0.38)
SCHEMBL142200 0.72
SCHEMBL4723234 0.67 TFPI2 (0.32)
SCHEMBL1468528 0.62
SCHEMBL27482403 0.61 SIGMAR1 (0.41)
SCHEMBL5561904 0.61
Hydrochloric Acid SCHEMBL4365776 0.60
SCHEMBL15750131 0.60 SIGMAR1 (0.39)
SCHEMBL4214811 0.59
SCHEMBL22032719 0.59 TFPI2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106946887-A It is a kind of to introduce the new technology that catalyst optimization synthesizes Dipyridamole 大连万福制药有限公司 2017-07-14 CN claimed
WO-2021043217-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF 中国科学院上海药物研究所 2021-03-11 WO disclosed
CN-106983751-A Two ring substituted uracils and application thereof 拜耳医药股份有限公司 2017-07-28 CN disclosed
CN-106946887-A It is a kind of to introduce the new technology that catalyst optimization synthesizes Dipyridamole 大连万福制药有限公司 2017-07-14 CN disclosed
CN-104395310-B Bicyclic substituted uracils and their use 拜耳药业股份公司 2017-05-03 CN disclosed
CN-104395310-A Bicyclic substituted uracils and their use Bayer Pharma AG 2015-03-04 CN disclosed
EP-1299362-A4 SELECTIVE MELANIN CONCENTRATING HORMONE-1 (MCH1) RECEPTOR ANTAGONISTS AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2004-11-03 EP disclosed
EP-1299362-A1 SELECTIVE MELANIN CONCENTRATING HORMONE-1 (MCH1) RECEPTOR ANTAGONISTS AND USES THEREOF Synaptic Pharmaceutical Corporation (US) 2003-04-09 EP disclosed
WO-2002006245-A1 SELECTIVE MELANIN CONCENTRATING HORMONE-1 (MCH1) RECEPTOR ANTAGONISTS AND USES THEREOF SYNAPTIC PHARMARCEUTICAL CORPORATION (US) 2002-01-24 WO disclosed